Company Monitoring Page for JNJ

latest headlines for company on cafepharma

1 Great Biotech Stock You Have Never Heard Of
Motley Fool
Sun, 10/1/17 - 09:59 am
Tags:
Halozyme Therapeutics, Roche, JNJ, Eli Lilly, Bristol-Myers Squibb
Apple, JNJ, Roche among companies selected for FDA digital health precertification pilot
BioPharma Dive
Thu, 09/28/17 - 09:45 am
Tags:
FDA, digital healthcare, Apple, JNJ, Samsung, Roche, Verily
Pfizer is falling short in a competitive market, Johnson & Johnson says as it hits back at Remicade biosimilar suit
Fierce Pharma
Tue, 09/26/17 - 09:39 pm
Tags:
Pfizer, JNJ, Remicade, Inflectra, biosimilars
J&J lines up its 4-in-1 HIV pill for FDA behind rivals from Gilead, GSK
Endpoints
Mon, 09/25/17 - 09:44 am
Tags:
JNJ, HIV, Gilead, GSK, FDA, D/C/F/TAF
FDA spurns J&J’s troubled rheumatoid arthritis drug sirukumab
Endpoints
Sat, 09/23/17 - 10:01 am
Tags:
FDA, JNJ, rheumatoid arthritis, sirukumab
J&J Alerted to Risk of Asbestos in Talc in '70s, Files Show
Newsmax
Sat, 09/23/17 - 09:57 am
Tags:
JNJ
Johnson & Johnson challenges $417M talc verdict, its largest defeat yet
Fierce Pharma
Thu, 09/21/17 - 10:12 pm
Tags:
JNJ
With help from J&J, upstart Provention lands rights to two mid-stage IBD drugs and shoots for PhII
Endpoints
Thu, 09/21/17 - 08:49 am
Tags:
JNJ, Provention Bio, IBD, inflammatory bowel disease, PRV-6527, Crohn's Disease, PRV-300, ulcerative colitis
This squabble between two big drugmakers could have major implications for the U.S. health care system
Marketwatch
Thu, 09/21/17 - 08:36 am
Tags:
JNJ, Pfizer, antitrust, biosimilars, Remicade, Inflectra
Pfizer files US lawsuit against Johnson & Johnson over "anticompetitive" practices related to Remicade biosimilar
First Word Pharma
Wed, 09/20/17 - 11:03 am
Tags:
Pfizer, JNJ, Janssen, Remicade, biosimilars, Inflectra
J&J, BARDA join forces to prep for pandemic flu, inking deal for vaccine and drug R&D
Fierce Pharma
Tue, 09/19/17 - 08:57 am
Tags:
JNJ, BARDA, pandemic flu, vaccines, R&D
10 Rock-Solid Reasons Johnson & Johnson's Near-Term Future Looks Bright
Motley Fool
Sun, 09/17/17 - 09:56 am
Tags:
JNJ, Remicade, Stelara, drug pricing, Imbruvica, Xarelto, Darzalex, devices, consumer health
Why Amgen, Lilly, J&J Are Interested In These Small Biotechs
Investors Business Daily
Sat, 09/16/17 - 12:11 pm
Tags:
Amgen, Eli Lilly, JNJ, Exelixis, biotech, Theravance, Bavarian Nordic, Agios, Biohaven Pharmaceuticals, Progenics
J&J moves away from hep C due to rival drugmakers' cures
BioPharma Dive
Mon, 09/11/17 - 10:28 pm
Tags:
JNJ, hepatitis C, JNJ-4178, R&D, hepatitis B
GSK, JnJ and Sanofi: potential buyers of Merck KGaA’s Consumer Health business
GoInPharma
Mon, 09/11/17 - 09:11 pm
Tags:
GSK, JNJ, Sanofi, Merck KGaA, consumer health, M&A
AbbVie and Pfizer hover at top, J&J Stelara surges in August TV pharma ad spend
Fierce Pharma
Mon, 09/11/17 - 09:06 pm
Tags:
AbbVie, Pfizer, JNJ, drug ads, television ads
J&J scraps a multibillion-dollar hepatitis C program after rivals divvy up the market
Endpoints
Mon, 09/11/17 - 09:40 am
Tags:
JNJ, Achillion, hepatitis C, odalasvir, ACH-3102
J&J’s Ethicon hit with $57m verdict in pelvic mesh case
Mass Device
Thu, 09/7/17 - 07:27 pm
Tags:
JNJ, Ethicon, pelvic mesh, devices
Takeda, Johnson & Johnson and more join Clara Health's Boston-based patient empowerment push
Fierce Pharma
Wed, 09/6/17 - 08:52 pm
Tags:
Takeda, JNJ, Clara Health, Amylyx Pharmaceuticals, patients, Boston
Texas Judge delays J&J Pinnacle hip implant bellwether trial
Mass Device
Wed, 09/6/17 - 08:35 pm
Tags:
JNJ, Pinnacle Hip, hip implants, devices, Texas, DePuy Ortho

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.